171 related articles for article (PubMed ID: 30942623)
1. Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes.
Li X; Jia F; Zhu Z; Huang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1256-1264. PubMed ID: 30942623
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
3. Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.
Wang Z; Xu M; Bai J; Ge G; Guo X; Yu B; Xiao L; Geng D; Hao Y
Eur J Pharmacol; 2019 Feb; 844():49-55. PubMed ID: 30452909
[TBL] [Abstract][Full Text] [Related]
4. Ivabradine abrogates TNF-α-induced degradation of articular cartilage matrix.
Xiang X; Zhou Y; Sun H; Tan S; Lu Z; Huang L; Wang W
Int Immunopharmacol; 2019 Jan; 66():347-353. PubMed ID: 30521963
[TBL] [Abstract][Full Text] [Related]
5. Licochalcone A Inhibits MMPs and ADAMTSs via the NF-κB and Wnt/β-Catenin Signaling Pathways in Rat Chondrocytes.
Chen WP; Hu ZN; Jin LB; Wu LD
Cell Physiol Biochem; 2017; 43(3):937-944. PubMed ID: 28957807
[TBL] [Abstract][Full Text] [Related]
6. Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis.
Gao F; Zhang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1043-1049. PubMed ID: 30942091
[TBL] [Abstract][Full Text] [Related]
7. Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo.
Ding QH; Ye CY; Chen EM; Zhang W; Wang XH
Int Immunopharmacol; 2018 Aug; 61():222-230. PubMed ID: 29890416
[TBL] [Abstract][Full Text] [Related]
8. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
Hu N; Gong X; Yin S; Li Q; Chen H; Li Y; Li F; Qing L; Yang J; Zhu S; Wang J; Li J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3239-3245. PubMed ID: 31364869
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin prevents articular cartilage matrix destruction in human chondrocytes.
Liu J; Cao L; Gao X; Chen Z; Guo S; He Z; Qian Y; Yu Y; Wang G
Biomed Pharmacother; 2018 Feb; 98():651-655. PubMed ID: 29291551
[TBL] [Abstract][Full Text] [Related]
10. Shikimic acid prevents cartilage matrix destruction in human chondrocytes.
Guo X; Wang L; Xu M; Bai J; Shen J; Yu B; Liu Y; Sun H; Hao Y; Geng D
Int Immunopharmacol; 2018 Oct; 63():155-160. PubMed ID: 30096598
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM).
Zha Z; Han Q; Huo S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1-7. PubMed ID: 31852246
[TBL] [Abstract][Full Text] [Related]
12. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
13. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.
Shan W; Qi J; Li C; Nie X
Arch Biochem Biophys; 2019 Nov; 677():108164. PubMed ID: 31678046
[TBL] [Abstract][Full Text] [Related]
14. The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation.
Zeng Y; Liu Z; Tan X; Lei L
Chem Biol Interact; 2020 Jul; 325():109088. PubMed ID: 32360554
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of rosmarinic acid on catabolism induced by IL-1β in rat chondrocyte.
Hu ZN; Huang LJ; Chen WP
Acta Biochim Pol; 2018 Dec; 65(4):535-538. PubMed ID: 30534634
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-7 antagonizes tumor necrosis factor-α-induced activation of nuclear factor κB and up-regulation of the ADAMTS, leading to decreased degradation of disc matrix macromolecules aggrecan and collagen II.
Wang Z; Hutton WC; Yoon ST
Spine J; 2014 Mar; 14(3):505-12. PubMed ID: 24176808
[TBL] [Abstract][Full Text] [Related]
17. Lycorine Suppresses Endplate-Chondrocyte Degeneration and Prevents Intervertebral Disc Degeneration by Inhibiting NF-κB Signalling Pathway.
Wang G; Huang K; Dong Y; Chen S; Zhang J; Wang J; Xie Z; Lin X; Fang X; Fan S
Cell Physiol Biochem; 2018; 45(3):1252-1269. PubMed ID: 29448253
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.
Zhang HB; Zhang Y; Chen C; Li YQ; Ma C; Wang ZJ
Apoptosis; 2016 Oct; 21(10):1082-93. PubMed ID: 27515513
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a-3p Regulates Aggrecanase-1 and Aggrecanase-2 Expression in Chondrogenesis and IL-1β-Induced Catabolism in Human Articular Chondrocytes.
Mao G; Wu P; Zhang Z; Zhang Z; Liao W; Li Y; Kang Y
Cell Physiol Biochem; 2017; 44(1):38-52. PubMed ID: 29241192
[TBL] [Abstract][Full Text] [Related]
20. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis.
Latourte A; Cherifi C; Maillet J; Ea HK; Bouaziz W; Funck-Brentano T; Cohen-Solal M; Hay E; Richette P
Ann Rheum Dis; 2017 Apr; 76(4):748-755. PubMed ID: 27789465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
